Shutterstock photo(RTTNews.com) - Gilead Sciences Inc. ( GILD ) is planning to appoint Daniel O'Day to take the helm and help the drug company revive sales and recover from a disappointing deal, the Wall Street Journal reported citing people familiar with the matter. O'Day, whose hiring could be announced as soon as Monday, would become Gilead Chief Executive Officer after a long career at Switzerland'sRoche Holding AG, most recently running its pharmaceuticals group, the report said. Gilead Sciences said in July that John Milligan would step down as President and Chief Executive Officer. Milligan would also step down from the Gilead Board at the end of the year. Read the original article on RTTNews (http://www.rttnews.com/2961257/wsj-gilead-sciences-plans-to-appoint-roche-executive-daniel-o-day-as-ceo.aspx)For comments and feedback: contact editorial@rttnews.comThis article appears in: World Markets , Stocks

Source: Wall Street Journal December 10, 2018 01:52 UTC